Navigation Links
Positive Results From Avanafil Phase 3 Study in Diabetics Presented at the 47th EASD Annual Meeting
Date:9/13/2011

MOUNTAIN VIEW, Calif., Sept. 13, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today presented positive results from the avanafil phase 3 study in diabetics.  In the REVIVE-Diabetes study (TA-302), male diabetics receiving avanafil had significant improvement in erectile function.  Dr. Irwin Goldstein, Director of Sexual Medicine at Alvarado Hospital, San Diego, CA, presented the results of the study during the poster session at the 47th European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbon, Portugal.  Results of the study have been previously reported, but this was the first public European presentation of avanafil safety and efficacy data in diabetic patients.  

The study included 390 patients with type 1 and type 2 diabetes treated over 12 weeks with avanafil 100mg, 200mg, or placebo.  Diabetics are disproportionately affected by erectile dysfunction (ED), which can worsen with increased duration of disease, and these patients are often considered less responsive to therapy.

This study population consisted of men with an average age of 58 years and a mean duration of diabetes of eleven years and ED of five to six years.  The majority were type 2 diabetics, with approximately 10% having type 1 diabetes.  Avanafil was associated with significant improvements in erectile function relative to placebo (calculated as least-squares (LS) mean change from baseline for all of the co-primary endpoints (P< 0.0001)).  Subgroup analyses demonstrated that improvements in the percentage of successful intercourse attempts with avanafil 100 mg and avanafil 200 mg were observed regardless of diabetes classification (type 1 or 2), duration of diabetes, or baseline ED severity (P<0.05).  Successful intercourse was achieved in some subjects in 15 minutes or less after dosing with avanafil.  S
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Positive Results from Phase 2 Clinical Study of NKTR-102 in Metastatic Breast Cancer Presented in Oral Session at the ASCO 2011 Breast Cancer Symposium
2. Initial Trial of Sanarias Malaria Vaccine Yields Positive Results
3. Metabolic Solutions Development Company Reports Positive Top-Line Results From Phase 2a Study of Its Second Compound to Treat Type 2 Diabetes
4. Auxilium Pharmaceuticals Announces Positive Data from Commercial Patient Chart Review in E-posters at ASSH Meeting
5. Auxilium Pharmaceuticals, Inc. Announces Positive Top-Line Results from XIAFLEX® Multi-Cord Study
6. Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
7. BioDelivery Sciences Announces Positive Results Supporting BEMA Buprenorphine/Naloxone Formulation for Opioid Dependence
8. Pearl Therapeutics Announces Positive Results for Phase 2b Dose-Ranging Study of Formoterol MDI
9. Curemark Reports Positive Results for Novel Compound CM-182 in Amphetamine Induced Hyperactivity
10. Bacterin Second Quarter 2011 Revenues up 135% Over Prior Year, Driving First Positive EBITDA Quarter
11. Phase 2 Trial of Lexicons LX1032, Telotristat Etiprate, Shows Positive Results in Carcinoid Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Aug. 22, 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) ... of units of common stock and warrants at a ... $20 million, prior to deducting underwriting discounts and commissions ... and warrants are immediately separable and will be issued ... begin trading on The NASDAQ Stock Market under the ...
(Date:8/21/2014)... 2014 Nektar Therapeutics (NASDAQ: ... positive results from its Phase 3 pivotal clinical ... recombinant factor VIII (rFVIII) treatment for hemophilia A ... its primary endpoint in reducing annualized bleed rates ... on-demand arm. Top-line results from the ...
(Date:8/21/2014)... 21, 2014 /CNW/ - Eisai Limited is pleased to support ... first-of-its-kind comic book available in Canada . ... specifically to educate children and their parents about epilepsy, the ... affecting more than 300,000 Canadians. Eisai is guided by a ... in which the patient is central – there was a ...
Breaking Medicine Technology:WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2
... 16 After more than 10 years of research and ... of a new company to build and market a breast ... as C.U.R.E. (Computerized Ultrasound Risk Evaluation), now referred to as ... Delphinus Medical Technologies, LLC. The company has already secured sale ...
... SAN DIEGO, Nov. 16 CareFusion (NYSE: ... announced a Web-based application that provides hospitals with on-demand ... costs. , The CareFusion Knowledge Portal is a remotely ... information dashboard to review metrics and actionable data directly ...
Cached Medicine Technology:Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 2Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 3Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 4Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 5CareFusion Launches Knowledge Portal to Provide Actionable Information Across Product Platforms 2CareFusion Launches Knowledge Portal to Provide Actionable Information Across Product Platforms 3
(Date:8/22/2014)... 22, 2014 With the stage set ... Total Store Expo - which will be held in ... pro-pharmacy op-ed in its online opinion section, Podium. ... ” is co-authored by Steven C. Anderson, IOM, CAE, ... dean of the MCPHS University School of Pharmacy – ...
(Date:8/22/2014)... The regional economy is about to ... on the grow again. The plant will invest ... to boost production of the popular Highlander midsize sport ... investment to $4 billion. This step allows Toyota to ... flexibility to adjust its product mix to meet changing ...
(Date:8/22/2014)... (HealthDay News) -- Many Americans know little about how Ebola ... an outbreak in the United States, a new survey shows. ... that there will be a major Ebola outbreak in the ... immediate family member will get sick with the deadly virus ... of Public Health poll. However, those opinions don,t match ...
(Date:8/22/2014)... 2014 Beat Eczema , Susan ... use natural methods to completely cure the eczema symptoms ... of Shane Michaels, prompting an investigative review. , ... skin, it can still be extremely debilitating and life-altering ... intense itching and pain that it causes on the ...
(Date:8/22/2014)... Epidermal growth factor receptor (EGFR) mutations found in the ... advanced non-small cell lung cancer (NSCLC) patients correlates well ... , EGFR tyrosine kinase inhibitor (TKI) therapy is approved ... but the standard for determining mutation status is with ... limited or not available. A more abundant and less ...
Breaking Medicine News(10 mins):Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 3Health News:Toyota Indiana Adding 300 Jobs to Build More Highlanders 2Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2Health News:Beat Eczema: Review Exposes Susan Clark’s Guide to Curing Eczema Naturally 2Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2
... European Society for Medical Oncology is proud to announce ... their commitment to providing excellent palliative care as part ... prestigious "ESMO Designated Centers of Integrated Oncology and Palliative ... comprehensive services in supportive and palliative care. The ...
... The SwitchTM programme, ,Switch what you Do, View, and Chew, ... and vegetable consumption and lowering ,screen time,. Researchers writing in ... programme and report that it offers promise for use in ... Iowa State University, USA, worked with a team of researchers ...
... , , FRIENDSWOOD, Texas, Sept. ... which develops, manages and owns faith-based senior living facilities, today ... lender for the development of a new senior living facility ... an 82-unit, $10 million senior living facility should be available ...
... WESTFORD, Mass., Sept. 22 Cynosure, Inc. (Nasdaq: CYNO ... light-based aesthetic treatment systems, today announced that President and Chief Executive ... at the third annual Maxim Group Growth Conference in New York ... webcast live over the Internet beginning at 10:00 a.m. (ET) Tuesday, ...
... to exaggerated fears as the real threat , TUESDAY, Sept. ... dire predictions and hastily ordered vaccines, could the growing worry ... outbreak? , That notion is weighing on the minds of ... winter flu season looms. , Not only does societal panic ...
... , RADNOR, Pa., Sept. 22 Eric Hipple, ... Feeling Blue Suicide Prevention Council,s Swing into Life! Golf Tournament, Wednesday, ... former National Football League (NFL) quarterback whose ten year career was ... a divisional championship, and the most valuable NFL player award for ...
Cached Medicine News:Health News:ESMO recognizes centers of excellence in palliative care for cancer patients 2Health News:Switch program increases kids' healthy eating, reduces screen time 2Health News:TrinityCare Senior Living Announces Expansion into Louisiana 2Health News:TrinityCare Senior Living Announces Expansion into Louisiana 3Health News:Cynosure to Present at the Maxim Group Growth Conference 2Health News:Could Swine Flu Panic Be Worse Than Outbreak Itself? 2Health News:Could Swine Flu Panic Be Worse Than Outbreak Itself? 3Health News:Could Swine Flu Panic Be Worse Than Outbreak Itself? 4Health News:Former NFL Quarterback to Speak at Local Nonprofit Fundraising Event 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: